It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.
Hover or tap a dot to see the filings behind that score.
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended November 30, 2024 (the “Quarterly Report”) will be delayed due to the additional time that is required to obtain and compile certain information required to be included in the Quarterly Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the Quarter Report within the five-calendar day extension period
NT 10-Q, filed 2025-01-14 · accounts not ready
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended November 30, 2024 (the “Quarterly Report”) will be delayed due to the additional time that is required to obtain and compile certain information required to be included in the Quarterly Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the Quarter Report within the five-calendar day extension period
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2024 (the “Annual Report”) will be delayed due to the additional time that is required to obtain and compile certain information required to be included in the Annual Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the Annual Report within the 15 calendar day extension period
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Quarterly Report on Form 10-Q for the quarter ended May 31, 2024 (the “Quarterly Report”) will be delayed due to the additional time that is required to obtain and compile certain information required to be included in the Quarterly Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the Quarterly Report within the five calendar day extension period
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2023 (the “November 30, 2023 Quarterly Report”) will be delayed due to the additional time that is required to obtain and compile certain information required to be included in the November 30, 2023 Quarterly Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the November 30, 2023 Quarterly Report within the five calendar day extension period
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2023 (the “2023 Annual Report”) will be delayed due to the additional time that is required to obtain and compile certain information required to be included in the 2023 Annual Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the 2023 Annual Report within the 15 calendar day extension period
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Quarterly Report on Form 10-Q for the quarter ended February 28, 2023 (the “Q2 Quarterly Report”) will be delayed due to the additional time that (i) was required to obtain and compile certain information required to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2022 (the “2022 Annual Report”), which was filed with the Securities and Exchange Commission (the “SEC”) on April 3, 2023; and (ii) is required to obtain and compile certain information required to be included in the Company’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2022 (the “Q1 Quarterly Report”) and in the Q2 Quarterly Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the Q2 Quarterly Report as soon as practicable following the filing of the Q1 Quarterly Report
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2022 (the “Quarterly Report”) will be delayed due to the additional time required to obtain and compile certain information required to be included in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2022 (the “Annual Report”) and in the Company’s Quarterly Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the Quarterly Report as soon as practicable following the filing of the Company’s Annual Report
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2022 (the “Annual Report”) will be delayed due to the additional time required to obtain and compile certain information required to be included in the Annual Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the Annual Report no later than December 14, 2022
2022-07-29auditor changed or resigned SEC →
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended November 30, 2021 (“Quarterly Report”) will be delayed due to the additional time required to obtain and compile certain information required to be included in its Quarterly Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the Quarterly Report no later than January 19, 2022
The filing by Novo Integrated Sciences, Inc. (the “Company”) of the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2021 (“Annual Report”) will be delayed due to the additional time required by a third party service provider to complete various valuation analyses of the Company’s intangible assets. The Company expects to file the Annual Report no later than December 14, 2021
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice